Company Valuation: Clarity Medical Group Holding Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024
Market Cap 1 637.1 496.4 359.1
Change - -22.08% -27.66%
Enterprise Value (EV) 1 416.1 336.2 243.1
Change - -19.19% -27.69%
P/E 36.2x -154x -4.71x
PBR 2.49x 1.91x 1.89x
PEG -0.6x 1x -0x
Capitalization / Revenue 2.83x 2.32x 1.88x
EV / Revenue 1.85x 1.57x 1.27x
EV / EBITDA 9.63x -218x -6.03x
EV / EBIT 11.7x -43.5x -4.32x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 0.0346 -0.006108 -0.1444
Distribution rate - - -
Net sales 1 225.2 213.8 190.9
EBITDA 1 43.19 -1.543 -40.34
EBIT 1 35.49 -7.722 -56.23
Net income 1 13.49 -3.191 -75.79
Net Debt 1 -221.1 -160.2 -116
Reference price 2 1.2500 0.9400 0.6800
Nbr of stocks (in thousands) 509,718 528,125 528,125
Announcement Date 27/07/22 28/07/23 26/07/24
1HKD in Million2HKD
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 24.29M
33.18x3.11x13.88x1.34% 18.32B
66.68x5.25x35.56x0.26% 13.33B
20.57x2.96x10.52x2.02% 11.45B
17.88x2.08x9.75x0.7% 10.93B
23.83x1.92x15.97x0.16% 9.77B
19.01x2.78x11.43x4.19% 9.36B
68.27x8.19x35.69x0.13% 7.66B
31.62x0.85x7.08x2.04% 6.71B
12.78x1.11x6.75x2.04% 6.9B
Average 32.65x 3.14x 16.29x 1.43% 9.44B
Weighted average by Cap. 33.48x 3.22x 16.79x 1.36%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 1406 Stock
  4. Valuation Clarity Medical Group Holding Limited